切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2016, Vol. 10 ›› Issue (04) : 396 -401. doi: 10.3877/cma.j.issn.1674-1358.2016.04.003

临床论著

代谢综合征对慢性HBV感染孕妇母婴结局的影响
许艳丽1,(), 刘华放1, 康晓迪1, 蒋红丽1   
  1. 1. 100015 北京,首都医科大学附属北京地坛医院妇产科
  • 收稿日期:2015-08-27 出版日期:2016-08-15
  • 通信作者: 许艳丽
  • 基金资助:
    市科委"首都临床特色应用研究"项目(No. Z141107002514131)

Influence of metabolic syndrome on maternal and fetal outcomes of women with chronic HBV infection

Yanli Xu1,(), Huafang Liu1, Xiaodi Kang1, Hongli Jiang1   

  1. 1. Department of Obstetrics and Gynecology, Beijing Ditan Hospital, Captial Medical University, Beijing 100015, China
  • Received:2015-08-27 Published:2016-08-15
  • Corresponding author: Yanli Xu
引用本文:

许艳丽, 刘华放, 康晓迪, 蒋红丽. 代谢综合征对慢性HBV感染孕妇母婴结局的影响[J/OL]. 中华实验和临床感染病杂志(电子版), 2016, 10(04): 396-401.

Yanli Xu, Huafang Liu, Xiaodi Kang, Hongli Jiang. Influence of metabolic syndrome on maternal and fetal outcomes of women with chronic HBV infection[J/OL]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2016, 10(04): 396-401.

目的

探讨代谢综合征(MS)对HBV感染孕妇母婴结局的影响。

方法

选择2011年7月至2014年7月于本院规律产检孕妇1 200例,分为H组(慢性HBV感染孕妇640例)及NH组(非HBV感染孕妇(无HBV及HCV感染560例),根据有无MS再分为H-M组(89例)、H-NM组(551例)、NH-M组(36例)及NH-HM(524例)。回顾性分析发生MS与不发生MS孕妇的母婴结局。

结果

H组患者MS的发生率(13.91%)高于NH组(4.64%)(χ2= 4.912、P = 0.027),平均孕前体重指数、孕期平均空腹血糖、平均餐后2 h血糖、孕期平均收缩压、平均舒张压、平均病毒载量、终止妊娠孕周,H-M组与H-NM组相比差异均具有统计学意义(P均<0.05)。妊娠期高血压疾病、妊娠期糖尿病、羊水过多、胎膜早破、妊娠期肝内胆汁淤积症、肝功能异常、剖宫产、阴道助产、产后出血、会阴裂伤和切口愈合不良等妊娠并发症的发生率,H-M组患者均显著高于H-NM组,NH-M组患者均显著高于NH-NM组,H组患者显著高于NH组,H-M组显著高于NH-M组,差异均具有统计学意义(P均<0.05)。新生儿结局胎儿窘迫、早产儿、低出生体重儿、巨大儿、新生儿低血糖、新生儿窒息的发生率方面,H-M组显著高于H-NM组,NH-M组高于NH-NM组,H组高于NH组,H-M组高于NH-M组,差异均具有统计学意义(P均<0.05)。H-M组新生儿HBV感染率高于H-NM组(χ2= 4.646,P = 0.024)。

结论

HBV感染孕妇较正常孕妇更易发生代谢综合征,且代谢综合征合并HBV感染者更易发生不良母婴结局,代谢综合征会影响孕期HBV病毒的复制以及母婴阻断的效果,应重视代谢综合征在HBV感染孕妇中的早期诊断、干预及预防。

Objective

To investigate the influence of metabolic syndrome on maternal and fetal outcomes of pregnant women with chronic HBV infection.

Methods

Total of 1 200 pregnant women were enrolled between July 2010 and July 2014. There were 640 women with chronic HBV infection were defined as HBV infection group (H group). Another 560 women without chronic HBV infection were defined as non-HBV infection group (NH group); 89 women with metabolic syndrome in HG group were defined as H-M group (H-M group); 551 women without metabolic syndrome in HG group were defined as H-NM group (H-NM group); 36 women with metabolic syndrome in NH group were defined as NH-M group (NH-M group); 524 women without metabolic syndrome in NH group were defined as NH-NM group (NH-NM group). Maternal and fetal outcomes of women in the groups were analyzed, retrospectively.

Results

The prevalence of MS in H group was 13.91% and significantly different from that of the NH group which was 4.64% (χ2= 4.912, P = 0.027). The BMI, FBG, PBG, systolic blood pressure, diastolic blood pressure and mean HBV DNA copies, delivery time in H-M group were significantly different compared with those of H-NM group (P all < 0.05). The incidence rate of the pregnant hypertension syndrome, gestational dibetes melliums, polyhydramnios, premature rupture of membranes, intrahepatic cholestasis of pregnancy, dysfunction of liver, the cesarean section, the vaginal midwifery, immediate postpartum hemorrhage, the perinea laceration, poor wound healing in H-M group were significantly different compared with those of H-NM group (P all < 0.05). The statistical differences of these indexes were also found between NH-M group and NH-NM group, between H goup and NH group, between H-MG and NH-MG (P all < 0.05). The incidence rates of adverse fatal outcomes: fetal distress, preterm infant, low birth weight infant, fatal macrosomia, neonatal hypoglycemia, neonatal asphyxia, in H-M group were significantly different compared to those of H-NM group. The statistical differences of these indexes were also found between NH-M group and NH-NM group, between H group and NH group, between H-M group and NH-M group. HBV infection rate of newborn in H-M group was significantly different compared to that in H-NM group (χ2= 4.646, P = 0.024).

Conclusions

The coexistence of HBV infection and metabolic syndrome in pregnanct women could induce more adverse pregnancy complications and fetal outcomes. Metabolic syndrome can influence the replication of HBV. Early diagnosis, prevent and intervension of the metabolic syndrome in pregnancy women with HBV infection should be strengthened.

表1 孕妇一般情况及代谢综合征相关指标
表2 入组患者妊娠并发症及妊娠结局
组别 例数 PIH [例(%)] GDM [例(%)] 羊水过多[例(%)] 胎膜早破[例(%)] ICP [例(%)] 肝功能异常[例(%)]
H组 640 132(20.63) 264(41.25) 39(6.09) 80(12.50) 165(25.78) 41(6.41)
H-M组 89 32(35.96) 46(51.69) 23(25.84) 46(51.68) 35(39.33) 30(33.71)
H-NM组 531 100(18.83) 218(41.05) 16(3.01) 34(6.40) 130(24.48) 11(2.07)
NH组 560 30(5.36) 48(8.57) 18(3.21) 14(2.50) 19(3.39) 26(4.64)
NH-M组 36 4(11.11) 19(52.78) 14(38.89) 9(25.00) 11(30.56) 16(44.44)
NH-NM组 524 32(6.11) 99(18.89) 24(4.58) 35(6.68) 8(1.53) 10(1.91)
χ21   4.701 4.155 3.881 4.233 3.948 3.925
χ22   3.895 3.903 4.012 4.214 4.230 4.195
χ23   4.232 5.229 4.352 5.237 3.911 4.235
χ24   4.246 4.268 4.190 4.267 5.895 4.709
P1   0.023 0.028 0.033 0.026 0.032 0.034
P2   0.038 0.031 0.029 0.027 0.026 0.027
P3   0.026 0.020 0.025 0.020 0.033 0.026
P4   0.025 0.025 0.027 0.025 0.016 0.023
组别 例数 剖宫产[例(%)] 阴道助产[例(%)] 产后出血[例(%)] 会阴裂伤(Ⅱ度以上)[例(%)] 切口愈合不良[例(%)] 分娩孕周( ±s,周)
H组 640 245(38.28) 26(4.06) 128(20.00) 29(4.53) 32(5.00) 37.5±3.6
H-M组 89 76(85.39) 8(8.99) 48(53.93) 10(11.24) 17(19.10) 37.3±4.2
H-NM组 531 169(31.83) 18(3.39) 80(15.07) 19(3.58) 15(2.82) 38.5±2.4
NH组 560 152(27.14) 14(2.50) 70(12.50) 8(1.41) 6(1.07) 38.4±6.1
NH-M组 36 17(47.23) 3(8.33) 8(22.22) 3(8.33) 2(5.56) 38.3±5.8
NH-NM组 524 165(31.49) 19(3.63) 82(15.65) 18(3.44) 7(1.34) 39.4±6.2
χ21   3.989 4.050 3.960 4.000 4.709 t1 = 3.963
χ22   4.780 3.937 3.851 4.239 4.363 t2 = 4.531
χ23   4.008 4.712 3.889 4.228 4.714 t3 = 4.739
χ24   3.911 5.900 4.243 3.962 5.880 t4 = 4.066
P1   0.034 0.030 0.032 0.030 0.023 0.022
P2   0.022 0.042 0.043 0.026 0.024 0.017
P3   0.028 0.023 0.038 0.027 0.023 0.015
P4   0.034 0.015 0.025 0.032 0.017 0.020
表3 入组新生儿的一般情况[例(%)]
1
中华医学会肝病学分会. 慢性乙型肝炎防治指南(2015年版)[J/CD]. 中国肝病学杂志:电子版,2015,7(3):1-18.
2
Reddick KL, Jhaveri R, Gandhi M, et al. Pregnancy outcomes associated with viral hepatitis[J]. J Viral Hepat,2011,18(7):e394-e398.
3
中华医学会糖尿病学分会代谢综合征研究协作组. 中华医学会糖尿病学分会关于代谢综合征的建议[J]. 中华糖尿病杂志,2004,12(3):156-161
4
Wiznitzer A, Mayer A, Novaek V, et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus:a population--based study[J]. Am J Obstet Gynecol,2009,201(5):e1-e8.
5
牛建民,雷琼,吕莉娟, 等. 妊娠期代谢综合征诊断标准的评价及危险因素分析[J]. 中华妇产科杂志,2013,48(2):92-97.
6
谢幸,苟文丽主编. 妇产科学[M]. 8版. 北京:人民卫生出版社:2013.
7
王卫平主编. 儿科学[M]. 8版. 北京:人民卫生出版社:2013
8
张弛,史艳明,游一平, 等. 妊娠期代谢综合征对母亲及胎儿的影响[A].中华医学会第十次全国内分泌学学术会议论文汇编[C]. 北京:中华医学会,2011:152-154.
9
Ray JG, Vermeulen MJ, Schull MJ, et al. Metabolic syndromeand the risk of placental dysfunction[J]. J Ohstet Gynaecol Can,2005,27(12):1095-1101.
10
Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region[J]. J Gastroenterol Hepatol,2000,15(Suppl):E3-E6
11
凌奕,吴小妹,陈泽俊, 等. 乙型肝炎病毒携带与妊娠期糖尿病关系的研究. 海南医学院学报,2011,17(8):1099-1100
12
Jonas MM. Hepatitis B and pregnancy: an underestimated issue[J]. Liver Int,2009,29(Suppl 1):133-139.
13
Söderström A, Norkrans G, Lindh M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission[J]. Scand J Infect Dis,2003,35:814-819.
14
Leung N. Chronic hepatitis B in Asian women of childbearing age[J]. Hepatol Int,2009,3(Suppl 1):24-31.
15
Li J, Wang R, Luo D, et a1. Association between serum ferritin levels and risk of the metabolic syndrome in Chinese adults: a population study[J]. PLoS One,2013,8(9):e74168.
16
Wang CC, Tseng TC, Kao JH. Hepatitis B virus infection and metabolic syndrome: fact or fiction?[J]. J Gastroentero Hepatol,2015,30(1):14-20.
17
陈建能,郑瑞丹,范建高, 等. 慢性乙型肝炎患者合并代谢综合征的临床特征[J]. 中华传染病杂志,2014,32(05):289-292
18
Wong GL, Chan HL, Yu Z, et al. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations[J]. Aliment Pharmacol Ther,2014,39(8):883-893.
19
Welzel TM, Graubard BI, Zeuzem S, et al. Metabolic syndrome increases the risk of primary liver cancer in the United States:a study in the SEER-Medicaredatabase[J]. Hepatology,2011,54(2):463-471.
20
Jarcuska P, Janicko M, Kruzliak P, et al. Hepatitis B virus infection in patientswith metabolic syndrome:a complicated relationship. Results of a population based study[J]. Eur J Intern Med,2014,25(3):286-291.
21
Martin J, Gabriela S, Sylvia D, et al. Association between metabolic syndrome and hepatitis B virus infection in the Roma population in eastern Slovakia: a population-based study[J]. Cent Eur J Publ Heal,2014,22(Suppl): S37-S42.
22
Yoon H, Lee JG, Yoo JH, et al. Effects of metabolic syndrome on fibrosis in chronic viral hepatitis E[J]. Gut Liver,2013,7(4):469-474.
23
Beltran-Sanchez H, Harhay MO, Harhay MM, et al. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010[J]. J Am Coil Cardiol,2013,62(8):697-703.
24
Lin YC, Hsiao ST, Chen JD. Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults[J]. World J Gastroenterol,2007,13(12):1805-1810.
25
Zhang F, Zhang Z, Kong D, et al. Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated P13K/AKT and ERK pathways[J]. Mol Cell Endocrinol,2014,382(1):197-204.
26
Lee JG, Lee S, Kim YJ, et al. Association of chronic viral hepatitis B with insulin resistance[J]. World J Gastroenterol,2012,18(42):6120-6126.
27
Targher G, Bertolini L, Padovani R, et al. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C[J]. J Hepatol,2007,46(6):1126-1132.
[1] 李钱梅, 何冠南, 赵婧, 陈曦, 唐玉英, 马丽琼, 梁蓉, 袁桃, 李明星. 早孕期低危妊娠和高危妊娠胎盘微血流成像特征及预后分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 726-732.
[2] 刘涵, 刘晓菲, 陈翰翰, 陈延君, 张雁. 妊娠期肉芽肿性乳腺炎一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(04): 253-254.
[3] 张舒沁, 陈练. 产后宫腔内妊娠物残留的诊断和临床处理[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 493-497.
[4] 刘子洋, 崔俭俭, 赵茵. 产科弥散性血管内凝血及其评分系统的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 511-518.
[5] 谢江燕, 王亚菲, 贺芳. 妊娠合并血栓性血小板减少性紫癜2例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 556-563.
[6] 韩肖燕, 杨桦. 中孕期孕妇血清胎盘生长因子水平低与胎儿不良预后的关系[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 398-402.
[7] 杜佳丽, 鲍睿, 乔春红, 韩伟. 中孕期宫颈功能不全孕妇经阴道紧急宫颈环扎术后不良妊娠结局预测模型构建[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 403-409.
[8] 张静, 刘畅, 华成舸. 妊娠期患者口腔诊疗进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(05): 340-344.
[9] 徐敬云, 丁波, 蒋宇慧, 沈杨. 妊娠期单孔腹腔镜手术实施行与思[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 262-266.
[10] 胡小靖, 张华. 妊娠期卵巢囊肿蒂扭转的诊断与治疗[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 197-201.
[11] 黎璞, 生秀杰. 妊娠合并子宫颈癌的管理[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 202-208.
[12] 俞慧慧, 尹宗智. 妊娠期胃穿孔[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 209-213.
[13] 何玉花, 钟欢妹, 王文惠, 沈永棋, 刘映云, 顾国威, 陈丹娜. 不同表型多囊卵巢综合征患者代谢指标及肥胖相关指标对多囊卵巢综合征合并代谢综合征人群的诊断效能分析[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(04): 212-220.
[14] 杭中霞, 王朝霞, 孙琴, 李妮. 血清Irisin、TSH 及Hcy 在妊娠期甲状腺功能减退症诊断中的应用[J/OL]. 中华诊断学电子杂志, 2024, 12(04): 265-269.
[15] 张鑫, 刘志芬, 郭云童. 肥胖与抑郁症相关性的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 255-260.
阅读次数
全文


摘要